Maccabi Fund

Maccabi Fund is the investment arm of Maccabi Healthcare Services, one of Israel’s largest health maintenance organizations, with a member base of millions and a longitudinal data infrastructure that few payers globally can match. The fund exists to back companies whose products benefit from being deployed and validated within Maccabi’s community care environment.

The thesis is structurally tied to Maccabi’s role as a payer and provider. The fund syndicates with eHealth Ventures and other partners to invest in startups whose advanced diagnostic algorithms, decision-support tools, and digital health products can be implemented and evaluated across Maccabi’s network. Portfolio activity concentrates on digital health and AI/ML in healthcare, with particular emphasis on predictive diagnostics, clinical AI, chronic disease management, and the broader category of payer-provider integrated digital health. AI is foundational across the portfolio rather than peripheral.

Checks fall in the one to five million dollar range at Seed and Series A. The fund is comfortable participating in syndicated rounds with eHealth Ventures and other healthcare investors, and the structure of investment is designed to support deployment and clinical validation within Maccabi’s network. Geography is centered on Israeli founders, with portfolio companies typically targeting both the Israeli market through Maccabi’s deployment infrastructure and global markets, primarily the US and Europe. The fund is positioned as a strategic partner that combines capital, clinical environment, and data access in a single relationship.

The team operates at the intersection of payer-provider economics, clinical research, and venture investment. Founders engage with the fund’s investment staff, with Maccabi’s clinical and operational leadership, and with co-investors in the syndicate. The diligence is heavy on clinical defensibility, integration feasibility within Maccabi’s environment, and the realistic path to broader commercialization beyond Israel. The relationship into Maccabi itself is the fund’s distinctive asset, providing access to longitudinal data, clinical workflows, and a deployment environment that few global investors can offer.

In practice, Maccabi Fund’s value to founders is unusual. It combines venture capital with the operational reality of a major payer-provider, providing both financial support and the clinical environment for validation and early deployment. The fund is direct about scope. It does not invest in companies that are not relevant to Maccabi’s clinical or operational priorities, and it is not a generalist healthcare investor. For founders building digital health and AI healthcare products that benefit from payer-provider integration and longitudinal data validation, the fund is one of the more strategically valuable partners in Israel. The conversations are operationally grounded, the deployment opportunities are real, and the founders who do well treat the relationship as a strategic partnership with Maccabi rather than as a passive financial investment.